ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Albireo wins back-to-back US, EU nods for bile acid modulator Bylvay firstwordpharma
July 21, 2021Albireo Pharma on Tuesday said the FDA cleared Bylvay (odevixibat) to treat moderate-to-severe itching in patients aged three months and older with progressive familial intrahepatic cholestasis (PFIC), making it the first drug approved for all subtypes of
Pharma Sources Insight January 2025
